| Structure | Chemical Name | CAS | MF |
|
1H-Imidazole-4-carboxylicacid,5-amino-2-propyl-,ethylester(9CI)
|
164535-24-4
|
C9H15N3O2
|
|
Pentanoic acid, 3-amino-2-propyl-
|
164575-79-5
|
C8H17NO2
|
|
S-[2-(4-Azidosalicylamido)ethylthio]-2-thiopyridine
|
164575-82-0
|
C14H13N5O2S2
|
|
Cyclopropane, 1-(4-bromo-3-buten-1-ynyl)-2-ethoxy-, [1alpha(Z),2ba]- (9CI)
|
164576-13-0
|
C9H11BrO
|
|
1,4-Benzenedicarboxylic acid, polymer with 1,2-ethanediol, hydrogen 1,3-dihydro-1,3-dioxo-5,6-isobenzofurandicarboxylate
|
164577-59-7
|
|
|
|
Disperse Yellow 184:1
|
164578-37-4
|
|
|
|
PantoprazoleSodiumSesquihydrate
|
164579-32-2
|
C16H15F2N3O4S.3/2H2O.Na
|
|
Benzenemethanamine, α-methyl-4-(2-methylpropyl)-, (S)- (9CI)
|
164579-51-5
|
C12H19N
|
|
SULFONAZO III, TITRATION INDICATOR FOR S O4
|
164581-28-6
|
C22H12N4Na4O14S4
|
|
L-Homocysteine, N,N-dimethyl- (9CI)
|
164581-38-8
|
C6H13NO2S
|
|
|
1H-Isoindol-3-amine,5-fluoro-1-imino-(9CI)
|
164581-64-0
|
C8H6FN3
|
|
3-HYDROXY-5,6-DIMETHOXY 1H-INDAZOLE
|
164582-90-5
|
C9H10N2O3
|
|
Methanimidamide, N-1H-imidazol-2-yl-N,N-dimethyl- (9CI)
|
164583-72-6
|
C6H10N4
|
|
PHENYL[2-(TRIMETHYLSILYL)PHENYL]IODONIUM TRIFLATE
|
164594-13-2
|
C16H18F3IO3SSi
|
|
4H-1-Benzopyran-3-carboxaldehyde, 7,8-dihydroxy-4-oxo- (9CI)
|
164594-34-7
|
C10H6O5
|
|
|
tropomyosin-4
|
164638-24-8
|
|
|
|
pyocin S3
|
164641-10-5
|
|
|
N-[1-(aminomethyl)cyclopentyl]-N,N-dimethylamine
|
164642-21-1
|
C8H18N2
|
|
4-T-BUTYLOXYCARBONYL-AMINOPROPYL-PYRIDINE
|
164648-58-2
|
C13H20N2O2
|
|
1H-Benzimidazole-5-methanamine(9CI)
|
164648-60-6
|
C8H9N3
|
|
Sulfamide, [4-(aminomethyl)phenyl]- (9CI)
|
164648-68-4
|
C7H11N3O2S
|
|
Sulfamide, (4-cyanophenyl)- (9CI)
|
164648-70-8
|
C7H7N3O2S
|
|
4-CYANOPHENYL N,N-DIMETHYLSULFAMATE
|
164648-84-4
|
C9H10N2O3S
|
|
|
2H-Pyran-2-methanol,tetrahydro-5-methyl-6-(1-methylethyl)-,[2S-(2alpha,5alpha,6bta)]-(9CI)
|
164649-90-5
|
C10H20O2
|
|
3-CHLORO-5-METHOXYBENZALDEHYDE
|
164650-68-4
|
C8H7ClO2
|
|
DIBENZYL N,N-DIMETHYLPHOSPHORAMIDITE
|
164654-49-3
|
C16H20NO2P
|
|
Dutasteride
|
164656-23-9
|
C27H30F6N2O2
|
|
3-Amino-6-chloro-2-picoline
|
164666-68-6
|
C6H7ClN2
|
|
METHYL 2-FORMYL-4-METHYL-4H-FURO[3,2-B]PYRROLE-5-CARBOXYLATE
|
164667-56-5
|
C10H9NO4
|
|
METHYL 4-METHYL-4H-FURO[3,2-B]PYRROLE-5-CARBOXYLATE
|
164667-61-2
|
C9H9NO3
|
|
4-PYRIDYLTHIOUREA
|
164670-44-4
|
C6H7N3S
|
|
5-BROMO-2,3-DIMETHOXY-BENZONITRILE
|
164670-73-9
|
C9H8BrNO2
|
|
|
cyclorenierin A
|
164672-55-3
|
|
|
Cyclopentanol, 1,2-dimethyl-5-(1-methylethyl)-, (1alpha,2ba,5ba)- (9CI)
|
164713-08-0
|
C10H20O
|
|
Cyclopentanol, 1,2-dimethyl-4-(1-methylethyl)-, (1alpha,2ba,4alpha)- (9CI)
|
164713-13-7
|
C10H20O
|
|
Ethanone, 1-(4,5-dihydro-2-hydroxy-3-pyridinyl)- (9CI)
|
164718-06-3
|
C7H9NO2
|
|
3-OCTADECANOYLUMBELLIFERONE
|
164720-09-6
|
C27H40O4
|
|
1-(4-fluorophenyl)piperidin-4-amine
|
164721-12-4
|
C11H15FN2
|
|
6-Benzothiazolol, 4-(methoxy-3-pyridinylmethyl)-5,7-dimethyl-2-(methylamino)-
|
164721-61-3
|
C17H19N3O2S
|
|
6-Benzothiazolol, 5,7-dimethyl-2-(methylamino)-4-[(1-methylethoxy)-3-pyridinylmethyl]-
|
164721-63-5
|
C19H23N3O2S
|
|
4-[(4-Chlorophenyl)phenylmethyl]-1-piperazineethanol dihydrochloride
|
164726-80-1
|
C19H25Cl3N2O
|
|
2-Propenamide, 2-methyl-3-(3-methyloxiranyl)- (9CI)
|
164727-46-2
|
C7H11NO2
|
|
Carbamic acid, (1,3-dimethyl-2-butenyl)-, 1,1-dimethylethyl ester (9CI)
|
164730-96-5
|
C11H21NO2
|
|
|
1H-2-Benzopyran,3,4-dihydro-3-methyl-3-phenyl-(9CI)
|
164731-59-3
|
C16H16O
|
|
|
1-Azetidinecarboxamide,N-propyl-(9CI)
|
164735-74-4
|
C7H14N2O
|
|
7-BROMO-1,2,3,4-TETRAHYDROCYCLOPENTA[B]INDOLE
|
164736-47-4
|
C11H10BrN
|
|
2H-Pyrrole,5-(3-fluorophenyl)-3,4-dihydro-(9CI)
|
164737-45-5
|
C10H10FN
|
|
4-Pyrimidinecarboxaldehyde, 2-methoxy- (9CI)
|
164738-44-7
|
C6H6N2O2
|
|
4-(TRIMETHYLSILYL)PYRIMIDINE
|
164738-48-1
|
C7H12N2Si
|
|
1-Piperazineaceticacid,2-oxo-,ethylester(9CI)
|
164784-87-6
|
C8 H14 N2 O3
|
|
Ethanone, 1-(2-amino-5-ethylphenyl)-2-chloro- (9CI)
|
164788-90-3
|
C10H12ClNO
|
|
Ethanone, 1-(2-amino-5-propylphenyl)-2-chloro- (9CI)
|
164788-92-5
|
C11H14ClNO
|
|
Ethanone, 1-[2-amino-5-(1-methylethyl)phenyl]-2-chloro- (9CI)
|
164788-93-6
|
C11H14ClNO
|
|
|
4-Thiomorpholinamine,3,3-dimethyl-(9CI)
|
164790-76-5
|
C6H14N2S
|
|
Bicyclo[1.1.1]pentane-1-carbonyl chloride, 3-bromo- (9CI)
|
164795-74-8
|
C6H6BrClO
|
|
|
Pyrido[4,3:4,5]pyrrolo[3,2-e]benzimidazole-2(1H)-thione, 3,6-dihydro-
|
164797-45-9
|
C12H8N4S
|
|
|
Pyrido[4,3:4,5]pyrrolo[3,2-e]benzimidazole-2(1H)-thione, 3,6-dihydro-7-phenyl-
|
164797-46-0
|
C18H12N4S
|
|
|
Pyrido[4,3:4,5]pyrrolo[3,2-e]benzimidazole, 1,6-dihydro-2-(methylthio)-
|
164797-47-1
|
C13H10N4S
|
|
Furo[3,4-b]furan-3-carboxylic acid, 4,6-dihydro- (9CI)
|
164797-59-5
|
C7H6O4
|
|
Propanamide, 2-(hydroxyimino)-N,N-dimethyl- (9CI)
|
164798-61-2
|
C5H10N2O2
|
|
3-Azabicyclo[3.1.0]hexane-6-carboxamide,6-amino-,(1alpha,5alpha,6beta)-(9CI)
|
164799-13-7
|
C6H11N3O
|
|
N-UNDECANE-D24
|
164858-54-2
|
C11D24
|
|
(R)-(+)-2-[2-(DIPHENYLPHOSPHINO)PHENYL]-4-(1-METHYLETHYL)-4,5-DIHYDROOXAZOLE
|
164858-78-0
|
C24H24NOP
|
|
2-Methyl-1-(3,4-dimethoxyphenyl)-1-(2-dimethylamino-4,5-dimethoxypheny l)propane
|
164859-57-8
|
|
|
|
Urinary Trypsin Inhibitor
|
164859-77-2
|
C40H66N14O9S1
|
|
HDBTU
|
164861-52-3
|
C12H16F6N5O2P
|
|
|
L-(+)-SWAINSONINE
|
164907-52-2
|
|
|
|
Glucoprotamin
|
164907-72-6
|
|
|
|
Reaction products of 4-nonylphenol, 1-dodecanethiol and formaldehyde
|
164907-73-7
|
|
|
|
Fluorescent brightener 378
|
164908-53-6
|
C30H26O2
|
|
3-NITROSALICYLIC ACID SODIUM SALT
|
164915-53-1
|
C7H4NNaO5
|
|
7-Nitro-3(2H)-benzofuranone
|
164915-57-5
|
C8H5NO4
|
|
Cyclopentanecarboxylic acid, 2-amino-4-fluoro-, (1alpha,2alpha,4alpha)- (9CI)
|
164916-31-8
|
C6H10FNO2
|
|
Cyclopentanecarboxylic acid, 2-(methylamino)-, cis- (9CI)
|
164916-43-2
|
C7H13NO2
|
|
|
3-Furancarboxylicacid,4-aminotetrahydro-,(3R,4S)-rel-(9CI)
|
164916-44-3
|
C5H9NO3
|
|
3-Thiophenecarboxylicacid,4-aminotetrahydro-,cis-(9CI)
|
164916-45-4
|
C5H9NO2S
|
|
CIS-1-BENZYL-3,4-PYRROLIDINEDICARBOXYLIC ACID
|
164916-63-6
|
C13H15NO4
|
|
N-Bromoisocyanuric acid monosodium salt
|
164918-61-0
|
C3HBrN3NaO2
|
|
Ethanone, 1-(4-amino-2-oxido-1,2,5-oxadiazol-3-yl)- (9CI)
|
164926-69-6
|
C4H6N3O3-
|
|
1,2,5-Oxadiazole-3-carboxamide,4-amino-N-methyl-,2-oxide(9CI)
|
164926-70-9
|
C4H6N4O3
|
|
1,2,5-Oxadiazole-3-carboxylicacid,4-amino-,ethylester,2-oxide(9CI)
|
164926-74-3
|
C5H7N3O4
|
|
4-Piperidineacetonitrile,1-methyl-(9CI)
|
164926-88-9
|
C8H14N2
|
|
2-(4-METHYL-PIPERAZIN-1-YL)-THIOACETAMIDE
|
164926-91-4
|
C7H15N3S
|
|
1H-Pyrazole-5-carboxylic acid, 4,5-dihydro-, methyl ester (9CI)
|
164928-01-2
|
C5H8N2O2
|
|
GAMMA,GAMMA-DIMETHYL-ALPHA-TRIFLUOROMETHYL-GAMMA-BUTYROLACTONE
|
164929-15-1
|
C7H9F3O2
|
|
2(1H)-Pyridinone, 3,4-diamino-5,6-dimethyl-
|
164930-92-1
|
C7H11N3O
|
|
(1R,2R)-(-)-[1,2-CYCLOHEXANEDIAMINO-N N'-BIS(3,5-DI-T-BUTYLSALICYLIDENE)]CHROMIUM (III) CHLORIDE
|
164931-83-3
|
C36H52ClCrN2O2
|
|
6-Oxa-3-azabicyclo[3.1.0]hexane, 3-(trifluoroacetyl)- (9CI)
|
164931-85-5
|
C6H6F3NO2
|
|
1,4-Benzenedicarbonitrile, 2-formyl- (9CI)
|
164932-42-7
|
C9H4N2O
|
|
Oxirane, 2-(1-hexynyl)-3-methyl-, (2R-cis)- (9CI)
|
164933-42-0
|
C9H14O
|
|
4-(5-BROMOTHIEN-2-YL)PYRIDINE
|
164936-60-1
|
C9H6BrNS
|
|
1-Propen-2-ol,1-(2-benzothiazolyl)-,(Z)-(9CI)
|
164976-51-6
|
C10H9NOS
|
|
|
poly(Tetrahydrofurandivinylether)
|
164978-32-9
|
|
|
3-(2,6-Dichlorophenyl)-N'-hydroxy-5-methylisoxazole-4-carboximidamide
|
164982-40-5
|
C11H9Cl2N3O2
|
|
ISOXAZOLE-5-CARBOXAMIDE OXIME
|
164982-41-6
|
|
|
2-(TERT-BUTYLSULFONYL)ACETAMIDE OXIME
|
164982-43-8
|
|
|
|
norzoanthamine
|
164991-65-5
|
|
|
4-Pentenoicacid,2-amino-2-methyl-,ethylester,(S)-(9CI)
|
165035-97-2
|
C8H15NO2
|
|
D-myo-Inositol, 1,4-bis(dihydrogen phosphate) 5-(S-(1-(2-nitrophenyl)e thyl) hydrogen phosphorothioate), (R)-
|
165036-14-6
|
|
|
2-Azetidinecarboxylicacid,3-methyl-4-oxo-,methylester,(2S-cis)-(9CI)
|
165036-27-1
|
C6H9NO3
|